Changchun Puhua

Changchun Puhua Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of ophthalmic preparations and other medicinal products. Headquartered in Changchun, the company is well-known for its extensive eye care portfolio, which includes treatments for cataracts and various inflammatory or infectious eye conditions. Beyond its core ophthalmology business, Changchun Puhua produces cardiovascular and cerebrovascular medications, including traditional Chinese medicine-based injections. The company operates modern manufacturing facilities that are fully compliant with Good Manufacturing Practice (GMP) standards. Changchun Puhua serves the domestic Chinese market through a combination of prescription drugs and over-the-counter (OTC) products and is listed on the National Equities Exchange and Quotations (NEEQ).